Due to technical advances, cancer research is producing information at an incredibly rapid pace challenging even the most tech-competent physicians to use these data to significantly improve actual patient care. An example is the current information about the cancer’s genome: millions of molecular alterations that might impact the growth of cancer cells have been discovered and might also influence the response to treatment. It has been estimated that the medical literature increases by doubling the amount of information every 3 years. So, a physician should read 29 hours per working day to stay updated about new cancer researches. The rapid development of artificial intelligence (AI) technology has begun to affect various fields. Medicine is one of the representative fields, and Watson for Oncology were trained by the collaboration between the IBM researchers and the Memorial Sloan Kettering Cancer Center. WFO can generate a ranked list of therapeutic options based on the new clinical trials, scientific articles, and any national and international guidelines. WFO achieved a high degree of concordance with tumor board recommendations. In addition to oncology, such technologies also have applications in radiology, pathology, and dermatology. We will discuss major issues related to WFO such as whether AI would replace human physicians, who would be responsible for the results, and how we regulate and validate the medical artificial intelligence.

Curriculum Vitae

※ Present title and Affiliation
Professor of Medicine, School of Meidicne, Keimyung University
Director, Keimyung University Institute for Cancer Research

※ Education/Research and Professional experience
1985-1991 M.D. Kyoungpook National University School of Medicine
1996-2002 Ph.D. Kyoungpook National University School of Medicine
1999-2000 Clinical Fellow, Hematology/Oncology, Asan Medical Center
2006-2007 Research Fellow, MD Anderson Cancer Center
2009-2016 Associate Professor, School of Meidicne, Keimyung University
2017-present Professor of Medicine, School of Meidicne, Keimyung University

※ Current Appointment of National/International activities
Member, Executive Board, Korean Cancer Association
Member, Executive Board, Korean Association of Clinical Oncology
Member, Executive Board, Korean Cancer Study Group
Member, American Association for Cancer Research
Member, American Society of Clinical Oncology
Reviewer, Cancer Research and Treatment